NEVRO CORP.
NVRO
NVRO was delisted on the 2nd of April, 2025.
170 hedge funds and large institutions have $1.5B invested in NEVRO CORP. in 2022 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 63 increasing their positions, 49 reducing their positions, and 33 closing their positions.
29% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 49
27% more call options, than puts
Call options by funds: $12M | Put options by funds: $9.46M
6% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 33
4% less funds holding
Funds holding: 177 → 170 (-7)
8% less capital invested
Capital invested by funds: $1.63B → $1.5B (-$126M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$34.6M |
| 2 |
Millennium Management
New York
|
+$26.6M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$20.1M |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$12.1M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$10.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$27.7M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$26.3M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$12.8M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$12M |
| 5 |
BlackRock
New York
|
-$11.4M |
NVRO Hedge Fund Activity: Q4 2022 in Review
170 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q4 2022, worth a combined $1.5B — down 7.7% from $1.63B a quarter earlier.
Sellers outnumbered buyers: 33 funds closed out of NVRO and 31 opened new positions — a net loss of 2 holders — while 49 trimmed existing stakes and 63 added.
The largest buyer was Fidelity Investments, adding an estimated $34.6M. The largest seller was T. Rowe Price Investment Management, exiting entirely with an estimated $27.7M sold.
- 170 institutional investors held NEVRO CORP. (NVRO) as of Q4 2022, down from 177 in Q3 2022.
- Funds reported $1.5B of NEVRO CORP. stock for Q4 2022, down 7.7% quarter-over-quarter.
- 31 funds opened new NEVRO CORP. positions in Q4 2022 and 33 closed out, a net change of -2 holders.
- The largest NEVRO CORP. buyer in Q4 2022 was Fidelity Investments, an estimated $34.6M added.
- The largest NEVRO CORP. seller in Q4 2022 was T. Rowe Price Investment Management, an estimated $27.7M sold.
Based on aggregated 13F filings for Q4 2022.